A South Korean research team has developed a porous nanocarrier that allows pharmaceuticals to be stored at room temperature without refrigeration [1].
This breakthrough addresses a critical vulnerability in global healthcare: the reliance on cold-chain logistics. Many temperature-sensitive medicines, including gene-based vaccines, currently require strict refrigeration to remain effective, which complicates distribution in remote or underdeveloped regions.
The technology was created at the KIST Bio Materials Research Center [1]. The system enables pharmaceuticals to be freeze-dried and stored in a stable state. When the medicine is needed, it can be rapidly restored to its active form simply by adding water [1].
According to the research team, the nanocarrier works by securing the necessary components within its structure. Student researcher Lee Si-an said the therapeutic agent and cryoprotectant are stably fixed inside the nanopores [1]. This stability prevents the degradation that typically occurs when sensitive biological drugs are exposed to room-temperature environments.
By eliminating the need for constant cooling, the nanocarrier could significantly reduce the cost and complexity of medical logistics. The ability to transport high-value medicines without expensive cooling equipment may increase the accessibility of life-saving treatments globally [1].
“The therapeutic agent and cryoprotectant are stably fixed inside the nanopores”
The transition from cold-chain to room-temperature storage represents a shift in pharmaceutical delivery. If scalable, this nanocarrier technology could remove the primary logistical barrier to distributing advanced genomic medicines and vaccines to the Global South, where reliable electricity for refrigeration is often unavailable.
